Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Taipei Veterans General Hospital, National Yang Ming University, Dalin Tzu Chi Hospital, China Medical University, China Medical University Hospital, National Taiwan University, Institute of Statistical Science, Academia Sinica, Academia Sinica, Taichung Veterans General Hospital, National Taiwan University Hospital, Tri-Service General Hospital, National Defense Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2287581527